Form D · Biotechnology

Auxilium Biotechnologies Inc.

San Diego, CA · CIK 0001800618

Offering snapshot reported Dec 11, 2025 · SEC filing

Reported sold: $3.94M
Investors reported: 16
Minimum accepted: $0
First sale: Sep 18, 2025

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$3,536,015 → $3,936,015
Reported investors14 → 16

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 11, 2025	Amendment	$3,936,015	$400,000vs Oct 23, 2025	16	SEC filing
Oct 23, 2025	Initial	$3,536,015	No comparison	14	SEC filing
Jan 21, 2020	Initial	$3,249,988	No comparison	18	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-561785

Amended to reflect the addition of two new investors and the corresponding update to the total amount sold and number of investors

Source: Form D, filed Dec 11, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Craig Andrews	Director
Donald Cohn	Director
Robert Engler	Director
Yacov Koffler	Director, Executive
Mark Tuszynski	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

3945 Carmel Springs Way
San Diego, CA, 92130